Evidence map›Paper›PMID 35634294›Full record

ArticleFrontiers in immunology2022

Stem Cells From Human Exfoliated Deciduous Teeth Alleviate Liver Cirrhosis

Peng Chen, Yi-Kun Zhou, Chun-Shan Han, Liu-Jing Chen, Yi-Ming Wang, Zi-Meng Zhuang, Shuai Lin, Yan-Heng Zhou, Jiu-Hui Jiang, Rui-Li Yang

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. [Progress in regulating stem cell functions for repair and regeneration of craniomaxillofacial tissues].Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences · 2026
    Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Exploring Cirrhosis: Insights into Advances in Therapeutic Strategies.International journal of molecular sciences · 2025
    Review
  7. Article
  8. Article
  9. Disulfiram in liver diseases: a double-edged sword.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Programmed Cell Death in Liver Fibrosis.Journal of inflammation research · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Peng ChenDepartment of Orthodontics, Peking University School and Hospital of Stomatology, Beijing, China.
Yi-Kun ZhouDepartment of Orthodontics, Peking University School and Hospital of Stomatology, Beijing, China.
Chun-Shan HanDepartment of Orthodontics, Peking University School and Hospital of Stomatology, Beijing, China.
Liu-Jing ChenDepartment of Orthodontics, Peking University School and Hospital of Stomatology, Beijing, China.
Yi-Ming WangDepartment of Orthodontics, Peking University School and Hospital of Stomatology, Beijing, China.
Zi-Meng ZhuangDepartment of Orthodontics, Peking University School and Hospital of Stomatology, Beijing, China.
Shuai LinDepartment of Orthodontics, Peking University School and Hospital of Stomatology, Beijing, China.
Yan-Heng ZhouDepartment of Orthodontics, Peking University School and Hospital of Stomatology, Beijing, China.
Jiu-Hui JiangDepartment of Orthodontics, Peking University School and Hospital of Stomatology, Beijing, China.
Rui-Li YangDepartment of Orthodontics, Peking University School and Hospital of Stomatology, Beijing, China.
National Clinical Research Center for Digestive Diseases · CNStomatology Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Liver cirrhosis represents a type of end-stage liver disease with few effective therapies, which was characterized by damaged functional liver tissue due to long-term inflammation. Gasdermin D (GSDMD)-executed programmed necrosis is reported to be involved in inflammation. However, the role of GSDMD in liver cirrhosis remains unclear. In this study, we used a CCl

Indexed as

NLR Family, Pyrin Domain-Containing 3 ProteinPyroptosisCaspase 1HepatocytesHumansInflammationIntracellular Signaling Peptides and ProteinsLiver CirrhosisPhosphate-Binding ProteinsStem CellsTooth, DeciduousCaspase 1Intracellular Signaling Peptides and ProteinsNLR Family, Pyrin Domain-Containing 3 ProteinPhosphate-Binding ProteinsGSDMDliver cirrhosisNLRP3pyroptosisstem cells from human exfoliated deciduous teeth

Identifiers

PMID35634294
PMCPMC9133376
OpenAlexW4280539438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.